|
- Idorsia | Welcome to Idorsia
A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as Idorsia’s representative for obtaining regulatory approvals in the EU
- Idorsia | About Idorsia
At Idorsia, we harness the power of difference to achieve business success: our employees come from diverse cultural backgrounds, representing over 33 nationalities We are committed to creating an inclusive culture that allows every employee to maximize their potential with equal opportunities
- Idorsia | Media release
Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team of professionals covering all disciplines from bench to bedside, state-of-the-art facilities, and a strong balance sheet – the ideal constellation to translate R D efforts into business success
- Idorsia Company Profile
Idorsia Company Profile Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is specialized in the discovery, development, and commercialization of transformative medicines Financial overview First Quarter
- Portfolio overview - Idorsia
A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as Idorsia’s representative for obtaining regulatory approvals in the EU
- Idorsia | Media release
Following the transfer of Actelion’s drug discovery and early-stage clinical pipeline business to Idorsia, registered Idorsia shares held by Actelion have been distributed to Actelion shareholders by way of a dividend in kind
- Our People - Idorsia
A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as Idorsia’s representative for obtaining regulatory approvals in the EU
- Investors - Idorsia
A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany – performs clinical development on behalf of the Group and acts as Idorsia’s representative for obtaining regulatory approvals in the EU
|
|
|